损害的CDK12活性导致对O-GlcNAc转移酶的高活性产生依赖
Satu Pallasaho1, Aishwarya Gondane1, Julia Kutz2
1Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki, Helsinki 00014, Finland.
向O-GlcNAc转移酶 (OGT) 和循环素依赖激酶12 (CDK12) 显示在前列腺癌中具有毒性. 抑制CDK12揭示SRPK1作为一个合成致命的目标,提供新的治疗策略.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- O-GlcNAc转移酶 (OGT) 对于细胞功能至关重要,并与转录调节剂如循环林依赖激酶12 (CDK12) 合作.
- CDK12是一种关键的转录延长激酶,其活性与包括前列腺癌在内的各种癌症有关.
研究的目的:
- 研究在前列腺癌中联合准OGT和CDK12的治疗潜力.
- 确定与前列腺癌中CDK12失活相关的新型治疗漏洞.
主要方法:
- 利用基于抑制剂和淘汰的策略来评估OGT和CDK12共同向的影响.
- 采用糖蛋白组学来分析O-GlcNAcylation在对CDK12抑制的反应中的变化.
- 综合糖蛋白组学,基因基本性和前列腺癌患者的临床数据.
主要成果:
- 同时准OGT和CDK12表明对前列腺癌细胞有毒性.
- 短期的CDK12抑制导致了结合体机械的超O-GlcNAcylation.
- 鉴定了氨酸-氨酸蛋白激酶1 (SRPK1) 作为合成致命的合作伙伴与CDK12失活.
结论:
- 降低CDK12活性的前列腺癌细胞对OGT和SRPK1抑制剂高度敏感.
- 在侵袭性前列腺癌中普遍存在的 CDK12 突变的非活化表明,结合酶体向疗法的潜在益处.
更多相关视频
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
相关概念视频
Inhibition of Cdk Activity
Positive Regulator Molecules
Positive Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Anaphase Promoting Complex
cAMP-dependent Protein Kinase Pathways
